Gene expression profiling in colorectal cancer using microarray technologies: Results and perspectives

Cancer Treatment Reviews

Volumn 35, Issue 3, 2009, Pages 201-209

  Nannini, Margherita ^a   Pantaleo, Maria Abbondanza ^a   Maleddu, Alessandra ^a   Astolfi, Annalisa ^b   Formica, Serena ^b   Biasco, Guido ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Affymetrix; Colorectal cancer; Gene expression profiling; Liver metastases; Microarray

Indexed keywords

AMPHIREGULIN; ANTINEOPLASTIC AGENT; CETUXIMAB; EPIREGULIN; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OSTEOPONTIN; OXALIPLATIN;

CANCER CLASSIFICATION; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CARCINOGENESIS; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL CARCINOMA; DISEASE FREE SURVIVAL; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HUMAN; METASTASIS POTENTIAL; MICROARRAY ANALYSIS; OVERALL SURVIVAL; PATIENT SELECTION; PREDICTION; PREOPERATIVE RADIOTHERAPY; PROGNOSIS; RECTUM CANCER; REVIEW; TREATMENT RESPONSE;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DNA, COMPLEMENTARY; DNA, NEOPLASM; DRUG MONITORING; FEMALE; FORECASTING; GENE EXPRESSION PROFILING; HUMANS; LIVER NEOPLASMS; MALE; MEDICAL ONCOLOGY; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; RNA, MESSENGER; RNA, NEOPLASM; TREATMENT OUTCOME;

EID: 64049091474     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2008.10.006     Document Type: Review

References (69)

1. Duftner N., Larkins-Ford J., Legendre M., and Hofmann H.A. Efficacy of RNA amplification is dependent on sequence characteristics: implications for gene expression profiling using a cDNA microarray. Genomics 91 (2008) 108-117
2. Jung S.H., Bang H., and Young S. Sample size calculation for multiple testing in microarray data analysis. Biostatistics 6 (2005) 157-169
3. Wadlow R., and Ramaswamy S. DNA Microarrays in clinical cancer research. Curr Mol Med 5 (2005) 111-120
4. Perou C.M., Sorlie T., Eisen M.B., et al. Molecular portraits of human breast tumours. Nature 406 (2000) 747-752
5. Sorlie T., Perou C.M., Tibshirani R., et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98 (2001) 10869-10874
6. West M., Blanchette C., Dressman H., et al. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci USA 98 (2001) 11462-11467
7. Zhao H., Langerød A., Ji Y., et al. Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Mol Biol Cell 15 (2004) 2523-2536
8. Hedenfalk I., Duggan D., Chen Y., et al. Gene-expression profiles in hereditary breast cancer. New Engl J Med 344 (2001) 539-548
9. van't veer L., Dai H., van de Vijver M.J., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415 (2002) 530-536
10. van de Vijver M.J., He Y., van't Veer L., et al. A gene expression signature as a predictor of survival in breast cancer. New Engl J Med 347 (2002) 1999-2009
11. Glinsky G.V., Higashiyama T., and Glinskii A.B. Classification of human breast cancer using gene expression profiling as a component of the survival predictor algorithm. Clin Cancer Res 10 (2004) 2272-2283
12. Wang Y., Klijn J.G., Zhang Y., et al. Gene expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365 (2005) 671-679
13. Chang J.C., Wooten E.C., Tsimelzon A., et al. Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer. Lancet 362 (2003) 362-369
14. Ayers M., Symmans W.F., Stec J., et al. Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer. J Clin Oncol 22 (2004) 2284-2293
15. Dressman H.K., Hans C., Bild A., et al. Gene expression profiles of multiple breast cancer phenotypes and response to neoadjuvant chemotherapy. Clin Cancer Res 12 (2006) 819-826
16. Chang J.C., Wooten E.C., Tsimelzon A., et al. Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients. J Clin Oncol 23 (2005) 1169-1177
17. Vogelstein B., Fearon E.R., Hamilton S.R., et al. Genetic alterations during colorectal-tumor development. New Engl J Med 319 (1988) 525-532
18. Spano J.P., Milano G., Vignot S., and Khayat D. Potential predictive markers of response to EGFR-targeted therapies in colorectal cancer. Crit Rev Oncol Hematol 66 (2008) 21-30
19. Alon U., Barkai N., Notterman D.A., et al. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc Natl Acad Sci USA 96 (1999) 6745-6750
20. Notterman D.A., Alon U., Sierk A.J., et al. Trascriptional gene expression profiles of colorectal adenoma, adenocarcinoma and normal tissue examined by oligonucleotide arrays. Cancer Res 61 (2001) 3124-3130
21. Kitahara O., Furukawa Y., Tanaka T., et al. Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia. Cancer Res 61 (2001) 3544-3549
22. Lin Y.M., Furukawa Y., Tsunoda T., et al. Molecular diagnosis of colorectal tumors by expression profiles of 50 genes expressed differentially in adenomas and carcinomas. Oncogene 21 (2002) 4120-4128
23. Zou T.T., Selaru F.M., Xu Y., et al. Application of cDNA microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colon. Oncogene 21 (2002) 4855-4862
24. Agrawal D., Chen T., Irby R., et al. Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J Natl Cancer Inst 94 (2002) 513-521
25. Williams N.S., Gaynor R.B., Scoggin S., et al. Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference. Clin Cancer Res 9 (2003) 931-946
26. Frederiksen C.M., Knudsen S., Laurberg S., and Ørntoft T.F. Classification of Dukes' B and C colorectal cancers using expression arrays. J Cancer Res Clin Oncol 129 (2003) 263-271
27. Kwon H.C., Kim S.H., Roh M.S., et al. Gene expression profiling in lymph node-positive and lymph node-negative colorectal cancer. Dis Colon Rectum 47 (2004) 141-152
28. Koheler A., Bataille F., Schmid C., et al. Gene expression profiling of colorectal cancer and metastases divides tumours according to their clinicopathological stage. J Pathol 204 (2004) 65-74
29. Bertucci F., Salas S., Eysteries S., et al. Gene expression profiling of colon cancer by DNA microarrays and correlation with histological parameters. Oncogene 23 (2004) 1377-1391
30. Croner R.S., Foertsch T., Brueckl W.M., et al. Common denominator genes that distinguish colorectal carcinoma from normal mucosa. Int J Colorectal Dis 20 (2005) 353-362
31. Kwong K.Y., Bloom G.C., Yang I., et al. Synchronous global assessment of gene and protein expression in colorectal cancer progression. Genomics 86 (2005) 142-158
32. Friederichs J., Rosenberg R., Mages J., et al. Gene expression profiles of different clinical stages of colorectal carcinoma: toward a molecular genetic understanding of tumor progression. Int J Colorectal Dis 20 (2005) 391-402
33. Bianchini M., Levy E., Zucchini C., et al. Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa. Int J Oncol 29 (2006) 83-94
34. Grade M., Hörmann P., Becker S., et al. Gene expression profiling reveals a massive, aneuploidy-dependent transcriptional deregulation and distinct differences between lymph node-negative and lymph node-positive colon carcinomas. Cancer Res 67 (2007) 41-56
35. Groene J., Mansmann U., Meister R., et al. Transcriptional census of 36 microdissected colorectal cancers yields a gene signature to distinguish UICC II and III. Int J Cancer 119 (2006) 1829-1836
36. Croner R.S., Förtsch T., Brückl W.M., et al. Molecular signature for lymphatic metastasis in colorectal carcinomas. Ann Surg 247 (2008) 803-810
37. Yanagawa R., Furukawa Y., Tsunoda T., et al. Genome-wide screening of genes showing altered expression in liver metastases of human colorectal cancers by cDNA microarray. Neoplasia 5 (2001) 395-401
38. Li M., Lin Y.-M., Hasegawa S., et al. Genes associated with liver metastasis of colon cancer, identified by genome-wide cDNA microarray. Int J Oncol 24 (2004) 305-312
39. Kleivi K., Lind G.E., Diep C.B., et al. Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatoses. Mol Cancer 6 2 (2007)
40. Ki D.H., Jeung H.C., Park C.H., et al. Whole genome analysis for liver metastasis gene signatures in colorectal cancer. Int J Cancer 121 (2007) 2005-2012
41. Lin H.M., Chatterjee A., Lin Y.H., et al. Genome wide expression profiling identifies genes associated with colorectal liver metastasis. Oncol Rep 17 (2007) 1541-1549
42. Komuro K., Tada M., Tamoto E., et al. Right- and left-sided colorectal cancers display distinct expression profiles and the anatomical stratification allows a high accuracy prediction of lymph node metastasis. J Surg Res 124 (2005) 216-224
43. Birkenkamp-Demtroder K., Olesen S.H., Sørensen F.B., et al. Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid. Gut 54 (2005) 374-384
44. Kita H., Hikichi Y., Hikami K., et al. Differential gene expression between flat adenoma and normal mucosa in the colon in a microarray analysis. J Gastroenterol 41 (2006) 1053-1063
45. Kim K., Park U., Wang J., et al. Gene profiling of colonic serrated adenomas by using oligonucleotide microarray. Int J Colorectal Dis 23 (2008) 569-580
46. Chan S.K., Griffith O.L., Tai I.T., and Jones S.J. Meta-analysis of colorectal cancer gene expression profiling studies identifies consistently reported candidate biomarkers. Cancer Epidem Biomar Prev 17 (2008) 543-552
47. Wang Y., Jatkoe T., Zhang Y., et al. Gene expression profiles and molecular markers to predict recurrence of Duke's B Colon Cancer. J Clin Oncol 22 (2004) 1564-1571
48. Eschrich S., Yang I., Bloom G., et al. Molecular staging for survival prediction of colorectal cancer patients. J Clin Oncol 23 (2005) 3526-3535
49. Arango D., Laiho P., Kokko A., et al. Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer. Gastroenterology 129 (2005) 874-884
50. Barrier A., Boelle P.Y., Lemoine A., et al. Gene expression profiling of nonneoplastic mucosa may predict clinical outcome of colon cancer patients. Dis Colon Rectum 48 (2005) 2238-2248
51. Barrier A., Lemoine A., Boelle P.Y., et al. Colon cancer prognosis prediction by gene expression profiling. Oncogene 24 (2005) 6155-6164
52. Barrier A., Boelle P.Y., Roser F., et al. Stage II colon cancer prognosis prediction by tumor gene expression profiling. J Clin Oncol 24 (2006) 4685-4691
53. Barrier A., Roser F., Boëlle P.Y., et al. Prognosis of stage II colon cancer by non-neoplastic mucosa gene expression profiling. Oncogene 26 (2007) 2642-2648
54. Cavalieri D., Dolara P., Mini E., et al. Analysis of gene expression profiles reveals novel correlations with the clinical course of colorectal cancer. Oncol Res 16 (2007) 535-548
55. D'Arrigo A., Belluco C., Ambrosi A., et al. Metastatic transcriptional pattern revealed by gene expression profiling in primary colorectal carcinoma. Int J Cancer 115 (2005) 256-262
56. Yamasaki M., Takemasa I., Komori T., et al. The gene expression profile represents the molecular nature of liver metastasis in colorectal cancer. Int J Oncol 30 (2007) 129-138
57. Mariadason J.M., Arango D., Shi Q., et al. Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin. Cancer Res 63 (2003) 8791-8812
58. Shimizu D., Ishikawa T., Ichikawa Y., et al. Prediction of chemosensitivity of colorectal cancer to 5-fluorouracil by gene expression profiling with cDNA microarrays. Int J Oncol 27 (2005) 371-376
59. Arango D., Wilson A.J., Shi Q., et al. Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells. Br J Cancer 91 (2004) 1931-1946
60. Del Rio M., Molina F., Bascoul-Mollevi C., et al. Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan. J Clin Oncol 25 (2007) 773-780
61. Khambata-Ford S., Garrett C.R., Meropol N.J., et al. Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab. J Clin Oncol 25 (2007) 3230-3237
62. Ghadimi B.M., Grade M., Difilippantonio M.J., et al. Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy. J Clin Oncol 23 (2005) 1826-1838
63. Kim I.J., Lim S.B., Kang H.C., et al. Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer. Dis Colon Rectum 50 (2007) 1342-1353
64. Rimkus C., Friederichs J., Boulesteix A.L., et al. Microarray-based prediction of tumor response to neoadjuvant radiochemotherapy of patients with locally advanced rectal cancer. Clin Gastroenterol Hepatol 6 (2008) 53-61
65. Linton K.M., Hey Y., Saunders E., et al. Acquisition of biologically relevant gene expression data by Affymetrix microarray analysis of archival formalin-fixed paraffin-embedded tumours. Br J Cancer 98 (2008) 1403-1414
66. Nadal C., Maurel J., and Gascon P. Is there a genetic signature for liver metastasis in colorectal cancer?. World J Gastroenterol 13 (2007) 5832-5844
67. Varghese S., Burness M., Xu H., Beresnev T., Pingpank J., and Alexander H.R. Site-specific gene expression profiles and novel molecular prognostic factors in patients with lower gastrointestinal adenocarcinoma diffusely metastatic to liver or peritoneum. Ann Surg Oncol 14 (2007) 3460-3471
68. Pantaleo MA, Astolfi A, Nannini M, Ercolani, et al. Gene expression profiling differences between synchronous and metachronous liver metastases of colorectal cancer. AACR-NCI-EORTC conference on molecular targets and cancer therapeutics. San Francisco; October 2007.
69. Weir B.A., Woo M.S., Getz G., et al. Characterizing the cancer genome in lung adenocarcinoma. Nature 450 (2007) 893-898